Glucowin-M 1 Tablet PR
Images are for reference. Actual packaging may vary.
Glimepiride (1mg) + Metformin (500mg)
1 units • Other
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glucowin-M 1 Tablet PR is a combination oral antidiabetic medication containing Glimepiride 1mg and Metformin 500mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, resulting in reduced blood glucose levels.
The prolonged-release formulation of Glucowin-M 1 ensures sustained drug release, promoting stable plasma concentrations and improving patient compliance through once-daily dosing. This combination is particularly beneficial for patients inadequately controlled on diet and exercise alone or monotherapy. Glucowin-M 1 should be used as part of a comprehensive diabetes management plan including diet, exercise, and regular monitoring of blood glucose levels.
Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to lactic acidosis. Common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, as well as hypoglycemia due to the sulfonylurea component. Regular monitoring of blood glucose and periodic assessment of renal function are recommended during therapy.
Glucowin-M 1 Tablet PR should be prescribed and used under medical supervision to optimize therapeutic outcomes and minimize risks.
How to use Glucowin-M Tablet PR Use it as advised by your doctor or check the label for directions before use. Glucowin-M 1 Tablet PR is to be taken with food.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
It is unsafe to consume alcohol with Glucowin-M 1 Tablet PR.
High Risk
Glucowin-M 1 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glucowin-M 1 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Glucowin-M 1 Tablet PR may be needed. Please consult your doctor. Glucowin-M 1 Tablet PR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Glucowin-M 1 Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Glucowin-M 1 Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Glucowin-M 1 Tablet PR may be needed. Please consult your doctor. Use of Glucowin-M 1 Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Glucowin-M 1 Tablet PR






